ClinVar Miner

Submissions for variant NM_000435.3(NOTCH3):c.3011G>A (p.Cys1004Tyr)

dbSNP: rs1555727944
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV000516299 SCV000614268 pathogenic not provided 2020-10-07 criteria provided, single submitter clinical testing This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). In some published literature, this variant is referred to as c.3089G>A. This variant has been identified in at least one individual with clinical features associated with this gene. Greater than 90% of NOTCH3 pathogenic mutations associated with CADASIL involve the gain or loss of a cysteine residue within the epidermal growth factor (EGF)-like repeat domain (PMID: 32457593, 20301673).
PreventionGenetics, part of Exact Sciences RCV003403217 SCV004110148 pathogenic NOTCH3-related condition 2023-03-06 criteria provided, single submitter clinical testing The NOTCH3 c.3011G>A variant is predicted to result in the amino acid substitution p.Cys1004Tyr. This variant was reported in an individual with CADASIL (Guerrot et al. 2008. PubMed ID: 18572291). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating it is rare. Most CADASIL causing variants in the NOTCH3 gene result in the gain or loss of one or more cysteine residues in the extracellular domain of the protein, as seen in this patient. This patient’s variant alters a cysteine residue and is located in the extracellular EGF-like domain 26. Pathogenic variants in EGF-like domains 1-6 appear to be fully penetrant and are usually associated with the classical CADASIL phenotype. However, there is variability in disease severity. Pathogenic variants in EGF-like domains 7-34 have a much higher population frequency, and can predispose to a milder small-vessel disease, possibly even displaying incomplete or at least very late onset complete penetrance (OMIM #125310; Rutten et al. 2016. PubMed ID: 27844030; Rutten et al. 2019. PubMed ID: 30032161). This variant is interpreted as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.